Skip to content
Back to Guavy Wire
Stocks

Measles Epidemic Hits US, Trump's Vaccine Order Criticized

Instruments
MRK
Share

The U.S. has seen over 2,484 cases of measles in 2026, according to the Johns Hopkins tracker, with hundreds of children hospitalized due to complications from the disease. Dr. Daniel Griffin, an expert in infectious diseases, has criticized President Trump's executive order to split the combined MMR vaccine into three separate shots and require each vaccination to be administered at a separate medical visit.

Griffin describes the order as 'built on lies' and notes that Merck, the sole U.S. manufacturer of the MMR vaccine, has declined to rebuild its supply line due to the significant costs involved. In fact, Japan abandoned using the individual measles vaccine in 1993 after a problematic mumps strain was introduced into the combination vaccine, resulting in a collapse of vaccination coverage and subsequent outbreaks.

Meanwhile, Lancast County, Pennsylvania has reported over 230 cases of measles, with dozens of hospitalizations in communities where antivaccine advocacy took root years earlier. The outbreak is linked to seed planted by RFK Jr., who warned a crowd of 1,500 at a farming fair that 'those agencies are going to do everything in their power to make the Amish vaccinated.'

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc